Upgrade to SI Premium - Free Trial

Celldex (CLDX)

39.68 +0.31 (0.79%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: Kynam Capital Management, LP August 14, 2026 12:09 PM - SEC Filing Form SCHEDULE 13G Celldex Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/ August 14, 2026 10:39 AM - SEC Filing Celldex Therapeutics (CLDX) PT Raised to $53 at Barclays August 7, 2026 4:53 AM - StreetInsider Form 10-Q Celldex Therapeutics, For: Jun 30 August 6, 2026 4:08 PM - SEC Filing Celldex (CLDX) Tops Q2 EPS by 12c August 6, 2026 4:05 PM - StreetInsider Form 8-K Celldex Therapeutics, For: Aug 06 August 6, 2026 4:02 PM - SEC Filing Celldex Reports Second Quarter Financial Results and Provides Corporate Update August 6, 2026 4:01 PM - Globe NewsWire Celldex Therapeutics (CLDX) PT Raised to $72 at Wells Fargo July 29, 2026 8:13 AM - StreetInsider Celldex Therapeutics (CLDX) PT Lowered to $40 at Morgan Stanley July 22, 2026 8:25 AM - StreetInsider Celldex Therapeutics (CLDX) PT Lowered to $61 at Cantor Fitzgerald July 22, 2026 6:59 AM - StreetInsider Celldex Therapeutics (CLDX) PT Lowered to $60 at Canaccord July 22, 2026 6:39 AM - StreetInsider Celldex Therapeutics (CLDX) PT Lowered to $48 at Wells Fargo July 22, 2026 6:26 AM - StreetInsider After-Hours Stock Movers: SMCI, OKLO, XE, PEGA, CLDX, ALK July 21, 2026 4:37 PM - StreetInsider Celldex's barzolvolimab fails Phase 2 trial in prurigo nodularis July 21, 2026 4:01 PM - StreetInsider Celldex Reports Results from Phase 2 Study of Barzolvolimab in Prurigo Nodularis July 21, 2026 4:01 PM - Globe NewsWire Celldex Therapeutics (CLDX) PT Raised to $100 at Guggenheim July 20, 2026 7:05 AM - StreetInsider Form 8-K Celldex Therapeutics, For: Jul 10 July 15, 2026 4:08 PM - SEC Filing Celldex CFO Sam Martin to retire in 2027 after nearly two decades July 15, 2026 4:01 PM - StreetInsider Celldex Announces Planned Transition of Chief Financial Officer July 15, 2026 4:01 PM - Globe NewsWire Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Lawver Teri L June 29, 2026 4:22 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Jimenez Freddy A. June 29, 2026 4:21 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Young Diane C. June 29, 2026 4:20 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Heath-Chiozzi Margo June 29, 2026 4:20 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Martin Samuel Bates June 29, 2026 4:19 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Cavanaugh Sarah June 29, 2026 4:18 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Crowley Elizabeth June 29, 2026 4:17 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: PEPIN RONALD June 29, 2026 4:16 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: KELER TIBOR June 29, 2026 4:15 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Marucci Anthony S June 29, 2026 4:14 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Torres Denice June 29, 2026 4:13 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Jain Rita June 29, 2026 4:12 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: NEIL GARRY ARTHUR June 29, 2026 4:11 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Cohen Cheryl June 29, 2026 4:10 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Brownlie Keith L June 29, 2026 4:09 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: MARINO JAMES J June 29, 2026 4:09 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: CONRAD HERBERT J June 29, 2026 4:07 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 25 Filed by: PENNER HARRY JR June 29, 2026 4:07 PM - SEC Filing Form S-8 Celldex Therapeutics, June 26, 2026 4:02 PM - SEC Filing Form 8-K Celldex Therapeutics, For: Jun 25 June 26, 2026 8:44 AM - SEC Filing Guggenheim flags this biotech stocks as one of its top picks June 18, 2026 11:00 PM - StreetInsider UBS Reiterates Buy Rating on Celldex Therapeutics (CLDX) June 16, 2026 9:28 AM - StreetInsider Celldex reports sustained angioedema improvements 7 months post-treatment June 14, 2026 2:00 PM - StreetInsider Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual June 14, 2026 10:21 AM - Globe NewsWire Celldex reports positive phase 1 results for bispecific antibody CDX-622 June 14, 2026 5:15 AM - StreetInsider Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting June 14, 2026 5:15 AM - Globe NewsWire Celldex to present mast cell targeting drug data at European congress June 10, 2026 4:01 PM - StreetInsider Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress  June 10, 2026 4:01 PM - Globe NewsWire Celldex Therapeutics (CLDX) PT Raised to $45 at UBS June 10, 2026 8:37 AM - StreetInsider Full Article List